BioArctic signed the first deal for its “brain transporter” with Bristol Myers Squibb late last year. The deal is worth up to $1.4bn and allows the US drugmaker to start trials using the technology to ...

An inert and unreactive gas may not seem like an obvious candidate for treating Alzheimer’s disease, yet a new study in mice ...

Kate joined Alzheimer’s Society as Chief Executive in March 2020, and is dedicated to providing help and hope to people affected by dementia to face some of the most frightening times of their lives.

As a person's dementia progresses, their dental needs may become more complicated. The person might need specialist treatment and mental capacity to consent to treatment may need to be assessed.

A New Psychoactive Substance (NPS) is a substance of abuse, either in a pure form or a preparation, that is not controlled by the 1961 Single Convention on Narcotic Drugs or the 1971 Convention on ...